(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial.
(Reporting by Puyaan Singh in Bengaluru)
AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study
Oct 20, 2025 | 7:12 AM
On Air Now
NikkiWeekdays | 6:00 AM - 12:00 PM
BelkyWeekdays | 12:00 PM - 6:00 PM
MikeWeekdays | 6:00 PM - 11:00 PM
OvernightsMonday | 11:00 PM - 12:00 AMMonday | 12:00 AM - 6:00 AMTuesday | 11:00 PM - 12:00 AMTuesday | 12:00 AM - 6:00 AMWednesday | 11:00 PM - 12:00 AMWednesday | 12:00 AM - 6:00 AMThursday | 11:00 PM - 12:00 AMThursday | 12:00 AM - 6:00 AMFriday | 11:00 PM - 12:00 AMFriday | 12:00 AM - 6:00 AM
WeekendsWeekends | 12:00 AM - 12:00 AM
Keyword: Text NEWS to 39327*
Details: Breaking News Alerts
Messages: expect up to 1 per week
Keyword: Text WEATHER to 39327*
Details: Daily Weather Forecast
Messages: expect up to 7 per week
Sponsor: King’s Campers
Keyword: Text TRAFFIC to 39327*
Details: Traffic and road alerts
Messages: expect up to 5 per week
*Message & data rates may apply. Text STOP to 39327 to quit. Text HELP for help or visit www.vibes.com/help/ for support. No purchase necessary. Marketing text messages generated by an automated dialer will be delivered to the phone number you provide at opt-in
Latest News
Czechs extend controls on Slovak border until Feb. 2
Jan 03, 2024
Comments